Celebrating fifteen years of operation is more than just marking an anniversary – it represents a journey of dedication, perseverance, and shared success. In 2024, the Kyrgyzstan branch of Berlin-Chemie Menarini reached a significant milestone, proudly reflecting on its achievements and the valuable contribution it has made since beginning its operations on behalf of the Menarini Group.

Over the years, Berlin-Chemie Menarini has strengthened its presence in Kyrgyzstan’s pharmaceutical sector, establishing a strong and recognizable brand. Its leadership in the region has continued to grow, driven by the high quality of its products and the dedication of a team of more than twenty highly skilled professionals.

Every day, these professionals work with a shared commitment to upholding the Menarini Group’s values and standards of excellence, ensuring patients have access to effective and reliable therapeutic solutions.

The company’s product portfolio includes treatments for a variety of conditions, such as cardiovascular diseases, diabetes, thyroid disorders, inflammatory conditions, gastrointestinal issues, hypertension, and allergies. The core of its business remains prescription medications, which make up the majority of its revenue.

However, Berlin-Chemie Menarini’s commitment extends far beyond simply supplying medications. A cornerstone of its mission is the continuous investment in medical and scientific education, reflected in its organization of highly valuable scientific and professional training events.

Among these, the Berlin-Chemie Menarini Cardio School and the Thyroid School have become flagship initiatives, attracting leading national and international experts. These programs play a key role in disseminating up-to-date medical knowledge to cardiologists, endocrinologists, and general practitioners throughout the region.

At the same time, the company is expanding its presence in the Consumer Healthcare sector. Over-the-counter (OTC) products are becoming an increasingly important segment of the market, now accounting for approximately one-third of total sales. This shift reflects a growing consumer preference for trusted and high-quality self-care solutions.

Berlin-Chemie Menarini’s success is built on two key factors: a highly motivated and cohesive team and a clear, forward-looking strategy that is closely aligned with the broader regional approach of Berlin-Chemie Menarini CEE & CIS.

With this strong foundation, the company is well-positioned to continue expanding its market presence and delivering innovative healthcare solutions that make a tangible difference in the lives of patients across Kyrgyzstan.